Loading company…
Univercells SA provides end-to-end biotech solutions for producing vaccines and biotherapeutics, based in Belgium.
Founded in 2013 and based in Charleroi, Belgium, Univercells SA offers biotech solutions for producing vaccines and biotherapeutics. The company was founded by CEO Hugues Bultot and CTO José Castillo. In October 2022 it raised EUR 44 million in Series D funding, co-led by 3d investors, Global Health Investment Corporation, Adjuvant Capital and AdBio Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in